|
EIF2S3 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.54119999487656E-08 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.15759998545684E-09 |
| Normal-vs-Stage2 |
1.454820E-01 |
| Normal-vs-Stage3 |
4.663500E-03 |
| Normal-vs-Stage4 |
5.011300E-04 |
| Stage1-vs-Stage2 |
3.409600E-02 |
| Stage1-vs-Stage3 |
1.130780E-01 |
| Stage1-vs-Stage4 |
5.705000E-01 |
| Stage2-vs-Stage3 |
4.205800E-01 |
| Stage2-vs-Stage4 |
1.375170E-01 |
| Stage3-vs-Stage4 |
4.594600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.349599985216E-09 |
| Normal-vs-AfricanAmerican |
9.848200E-01 |
| Normal-vs-Asian |
8.384400E-02 |
| Caucasian-vs-AfricanAmerican |
2.793100E-04 |
| Caucasian-vs-Asian |
3.550600E-01 |
| AfricanAmerican-vs-Asian |
1.605850E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.997100E-04 |
| Normal-vs-Female |
1.32980293443552E-11 |
| Male-vs-Female |
6.07899999999217E-05 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.990820E-01 |
| Normal-vs-Age(41-60Yrs) |
2.94509999998471E-06 |
| Normal-vs-Age(61-80Yrs) |
5.58880000056661E-08 |
| Normal-vs-Age(81-100Yrs) |
7.885800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.666400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.275800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.200000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.254000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.154100E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.556800E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
2.139200E-03 |
| Normal-vs-Grade 2 |
1.29619981414919E-10 |
| Normal-vs-Grade 3 |
1.777650E-04 |
| Normal-vs-Grade 4 |
2.404600E-01 |
| Grade 1-vs-Grade 2 |
4.946600E-01 |
| Grade 1-vs-Grade 3 |
5.903600E-01 |
| Grade 1-vs-Grade 4 |
8.531800E-02 |
| Grade 2-vs-Grade 3 |
4.902300E-02 |
| Grade 2-vs-Grade 4 |
8.179200E-04 |
| Grade 3-vs-Grade 4 |
8.384300E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.85940152164221E-12 |
| Normal-vs-ccB subtype |
1.116340E-02 |
| ccA subtype-vs-ccB subtype |
1.363570E-03 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.7004999998167E-07 |
| Normal-vs-N1 |
4.053800E-01 |
| N0-vs-N1 |
3.819600E-01 |
|
|
